NCT04083599 2026-03-16GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid TumorsGenmabPhase 1/2 Active not recruiting350 enrolled
NCT04198766 2025-12-18Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Inhibrx Biosciences, IncPhase 1/2 Active not recruiting296 enrolled
NCT02817633 2025-10-28A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)Tesaro, Inc.Phase 1 Active not recruiting463 enrolled
NCT06839105 2025-05-31A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced MalignanciesShanghai Junshi Bioscience Co., Ltd.Phase 1 Recruiting214 enrolled